JPS525777A - 1,4-dihydroxypyridine derivatives - Google Patents

1,4-dihydroxypyridine derivatives

Info

Publication number
JPS525777A
JPS525777A JP51079413A JP7941376A JPS525777A JP S525777 A JPS525777 A JP S525777A JP 51079413 A JP51079413 A JP 51079413A JP 7941376 A JP7941376 A JP 7941376A JP S525777 A JPS525777 A JP S525777A
Authority
JP
Japan
Prior art keywords
alkyl
substituted
cyano
formula
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP51079413A
Other languages
English (en)
Other versions
JPS5948827B2 (ja
Inventor
Yoshinari Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of JPS525777A publication Critical patent/JPS525777A/ja
Publication of JPS5948827B2 publication Critical patent/JPS5948827B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
JP51079413A 1975-07-02 1976-07-02 １，４−ジヒドロピリジン誘導体 Expired JPS5948827B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB27945/75A GB1552911A (en) 1975-07-02 1975-07-02 1,4 dihydropyridine derivatives and the preparation thereof
GB3985475 1975-09-29
GB5152475 1975-12-16
GB1376176 1976-04-05

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP59091231A Division JPS6012324B2 (ja) 1975-07-02 1984-05-07 １，４―ジヒドロピリジン誘導体を含有する血管拡張剤および血圧降下剤
JP59091232A Division JPS601154A (ja) 1975-07-02 1984-05-07 １，４−ジヒドロピリジン誘導体中間体

Publications (2)

Publication Number Publication Date
JPS525777A true JPS525777A (en) 1977-01-17
JPS5948827B2 JPS5948827B2 (ja) 1984-11-29

Family

ID=27448211

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51079413A Expired JPS5948827B2 (ja) 1975-07-02 1976-07-02 １，４−ジヒドロピリジン誘導体

Country Status (19)

Country Link
US (1) US4145432A (ja)
JP (1) JPS5948827B2 (ja)
AR (2) AR213097A1 (ja)
AU (1) AU510353B2 (ja)
CH (3) CH629778A5 (ja)
DD (1) DD126722A5 (ja)
DE (1) DE2629892A1 (ja)
DK (1) DK298176A (ja)
FI (1) FI61696C (ja)
FR (1) FR2315930A1 (ja)
GB (1) GB1552911A (ja)
GR (1) GR60422B (ja)
IE (1) IE43408B1 (ja)
IT (1) IT1068561B (ja)
MX (1) MX3591E (ja)
NL (1) NL190812C (ja)
PH (1) PH13772A (ja)
SE (1) SE434049B (ja)
YU (2) YU41562B (ja)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5395977A (en) * 1976-12-17 1978-08-22 Fujisawa Pharmaceut Co Ltd 1,4-dihydropyrimidine compounds and process for their preparation
JPS5826872A (ja) * 1981-07-30 1983-02-17 バイエル・アクチエンゲゼルシヤフト 心臓収縮性増進剤
JPS58185821U (ja) * 1982-06-02 1983-12-10 日産自動車株式会社 ウインドシ−ルド
JPS5927871A (ja) * 1982-08-06 1984-02-14 Banyu Pharmaceut Co Ltd ２−カルバモイルオキシアルキル−１，４−ジヒドロピリジン誘導体の新規な製造法
JPS6157578A (ja) * 1984-08-17 1986-03-24 ジヨン・ワイス・アンド・ブラザー・リミテツド 複素環式化合物
JPS62145064A (ja) * 1985-12-13 1987-06-29 バイエル・アクチエンゲゼルシヤフト 新規なフツ素含有１，４−ジヒドロピリジン類
JPS62155280A (ja) * 1985-12-18 1987-07-10 バイエル・アクチエンゲゼルシヤフト ４−チエニル−ジヒドロピリジン類
JPS62190187A (ja) * 1986-01-11 1987-08-20 バイエル・アクチエンゲゼルシヤフト ４−アミノアリ−ルジヒドロピリジンラクトン類
JPS62292757A (ja) * 1986-06-12 1987-12-19 Taisho Pharmaceut Co Ltd １，４−ジヒドロピリジン誘導体
JPS63211266A (ja) * 1978-09-08 1988-09-02 Fujisawa Pharmaceut Co Ltd ジヒドロピリジン誘導体の中間体

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370334A (en) * 1975-07-02 1983-01-25 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydro-pyridine derivatives and methods of using same
DE2639257A1 (de) * 1976-09-01 1978-03-02 Bayer Ag Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2658183A1 (de) * 1976-12-22 1978-07-06 Bayer Ag In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4466972A (en) * 1977-06-20 1984-08-21 Sandoz Ltd. Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them
FI64938C (fi) * 1977-06-20 1984-02-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat
DE2738153A1 (de) * 1977-08-24 1979-03-08 Bayer Ag 2-pyridyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
DE2841667A1 (de) * 1978-09-25 1980-04-10 Bayer Ag Fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
DE3022030A1 (de) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
CS228917B2 (en) 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
JPS57171968A (en) * 1981-04-17 1982-10-22 Kyowa Hakko Kogyo Co Ltd 1,4-dihydropyridine derivative
JPS57175164A (en) * 1981-04-18 1982-10-28 Banyu Pharmaceut Co Ltd 1,4-dihydropyridine derivative and its preparation
JPS57175166A (en) 1981-04-23 1982-10-28 Banyu Pharmaceut Co Ltd Carbamoyloxyalkyl-1,4-dihydropyridine derivative and its preparation
DE3130041A1 (de) * 1981-07-30 1983-02-17 Bayer Ag, 5090 Leverkusen Dihydropyridine mit positiv inotroper wirkung, neue verbindungen, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung
EP0080220B1 (en) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
US4497808A (en) * 1981-12-30 1985-02-05 Ciba-Geigy Corporation N-Oxide compounds useful in the treatment of cardiovascular ailments
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
DE3209276A1 (de) * 1982-03-13 1983-09-15 Bayer Ag, 5090 Leverkusen Arzneimittel mit antihypoxischer und ischaemie-protektiver wirkung
DE3209274A1 (de) * 1982-03-13 1983-09-15 Bayer Ag, 5090 Leverkusen Pyridincarbonsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS58208271A (ja) * 1982-04-30 1983-12-03 Kyowa Hakko Kogyo Co Ltd １，４−ジヒドロピリジン誘導体
IL68604A0 (en) * 1982-05-21 1983-09-30 Haessle Ab Processes for preparing therapeutically active dihydropyridines and intermediates for the processes
DE3379107D1 (en) * 1982-06-03 1989-03-09 Pierrel Spa Hydroxyimino and alkoxyimino derivatives of 1,4-dihydropyridine, process for the preparation thereof and pharmaceutical composition therefrom
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
HU192166B (en) * 1982-08-06 1987-05-28 Banyu Pharma Co Ltd Process for producing 2-carbamoyl-oxy-alkyl-1,4-dihydro-pyridine derivatives
EP0107293A3 (en) * 1982-09-04 1984-06-06 Pfizer Limited Dihydropyridines
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
EP0111455A3 (de) * 1982-12-10 1984-07-25 Ciba-Geigy Ag Ungesättigte Lactone
DE3247118A1 (de) * 1982-12-20 1984-06-20 Cassella Ag, 6000 Frankfurt Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4515799A (en) * 1983-02-02 1985-05-07 Pfizer Inc. Dihydropyridine anti-ischaemic and antihypertensive agents
EP0125803A3 (en) * 1983-04-27 1987-01-21 FISONS plc Pharmaceutically active dihydropyridines
US4686217A (en) * 1983-04-27 1987-08-11 Fisons Plc Calcium antagonist 2-fluoroalkyl-1,4-dihydropyridines
DE3319956A1 (de) * 1983-06-01 1984-12-06 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
AU561213B2 (en) * 1983-06-02 1987-04-30 Teijin Limited 1, 4-dihydropyridine derivative
DE3343658A1 (de) * 1983-12-02 1985-06-13 Bayer Ag, 5090 Leverkusen Hydroxy-tetrahydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
JPS60156671A (ja) * 1984-01-25 1985-08-16 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体およびその製造法
DE3410645A1 (de) * 1984-03-23 1985-09-26 Bayer Ag, 5090 Leverkusen L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
JPS6127711A (ja) * 1984-07-06 1986-02-07 Sumitomo Rubber Ind Ltd タイヤ識別用バーコード付きタイヤ及びタイヤの自動識別方法
GB8421039D0 (en) * 1984-08-17 1984-09-19 Wyeth John & Brother Ltd Heterocyclic compounds
US4975440A (en) * 1984-09-28 1990-12-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Optically-active 1,4-dihydropyridine
NO854021L (no) * 1984-10-26 1986-04-28 Bayer Ag 1,4-dihydropyridin-hydroksyaminer og fremgangsmaate til fremstilling derav.
DE3443179A1 (de) * 1984-11-27 1986-05-28 Cassella Ag, 6000 Frankfurt 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung
GB8503428D0 (en) * 1985-02-11 1985-03-13 Ici Plc Nitrogen-containing compounds
GB8503429D0 (en) * 1985-02-11 1985-03-13 Ici Plc Chemical compounds
US4652573A (en) * 1985-03-14 1987-03-24 Nelson Research & Development Co. Calcium antagonist N-hetero ester 1,4-dihydropyridines
JPS625958A (ja) * 1985-07-03 1987-01-12 Suntory Ltd １，４−ジヒドロピリジン誘導体、その製造法および循環系疾患治療剤
IT1215298B (it) * 1985-08-06 1990-01-31 Boehringer Biochemia Srl 2-(eteroalchil)-1,4-diidropiridine ed un processo per la loro produzione.
EP0226271B1 (en) * 1985-08-21 1990-11-22 GLAXO S.p.A. 1,4-dihydropyridine compounds and their preparation and pharmaceutical formulation
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines
JPS63115890A (ja) * 1986-10-31 1988-05-20 Nippon Shinyaku Co Ltd ２位置換１，４−ジヒドロピリジン誘導体
DE3706204A1 (de) * 1987-02-26 1988-09-08 Bayer Ag Benzylaminoaryl-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
EP0343193A1 (de) * 1987-03-27 1989-11-29 Byk Gulden Lomberg Chemische Fabrik Gmbh 1,4-dihydropyridine-enantiomere
GB8710493D0 (en) * 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
IT1229118B (it) * 1988-07-29 1991-07-22 Simes Composti attivi sul sistema cardiovascolare che presentano sia la struttura dei beta-bloccanti sia una porzione calcio-antagonista
US5571827A (en) * 1990-03-13 1996-11-05 Sepracor Inc. Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
US5254692A (en) * 1990-04-06 1993-10-19 Bayer Aktiengesellschaft 2,6-dialkyl-4-(benzothiazol- or benzoxazol-7-yl)-1,4-dihydropyridines
DE4134760A1 (de) * 1991-10-22 1993-07-08 Bayer Ag Aryl-chinolyl-substituierte 1,4-dihydropyridin-dicarbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4202526A1 (de) * 1992-01-30 1993-08-05 Bayer Ag Neue 4-cinnolinyl- und 4-naphthyridinyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
JPH08502263A (ja) * 1992-10-06 1996-03-12 セプラコア，インコーポレーテッド 光学的に純粋なｓ（−）ニトレンジピンを用いる高血圧、狭心症、その他の疾患の治療方法および組成物
DE4313690A1 (de) * 1993-04-27 1994-11-03 Bayer Ag Kondensierte Chinolyl-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313691A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2,6-Disubstituierte 4-Chinolyl-dihydropyridine
DE4313697A1 (de) * 1993-04-27 1994-11-03 Bayer Ag Chinolyl-dihydropyridinester, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313692A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 3-Chinolyl substituierte Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946027A (en) * 1972-09-30 1976-03-23 Bayer Aktiengesellschaft 3,5,6-Tricarboxy-4-pyridyl-1,4-dihydropyridine derivatives
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
DE2310747A1 (de) * 1973-03-03 1974-09-12 Bayer Ag Verfahren zur herstellung von neuen amino-3,4-dihydropyridinen und ihre verwendung als arzneimittel
DE2335466A1 (de) * 1973-07-12 1975-01-30 Bayer Ag Alkoxyalkyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CH607848A5 (ja) * 1974-06-04 1978-11-30 Bayer Ag

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5948828B2 (ja) * 1976-12-17 1984-11-29 藤沢薬品工業株式会社 １．４↓−ジヒドロピリジン化合物およびその製造法
JPS5395977A (en) * 1976-12-17 1978-08-22 Fujisawa Pharmaceut Co Ltd 1,4-dihydropyrimidine compounds and process for their preparation
JPH0121827B2 (ja) * 1978-09-08 1989-04-24 Fujisawa Pharmaceutical Co
JPS63211266A (ja) * 1978-09-08 1988-09-02 Fujisawa Pharmaceut Co Ltd ジヒドロピリジン誘導体の中間体
JPS5826872A (ja) * 1981-07-30 1983-02-17 バイエル・アクチエンゲゼルシヤフト 心臓収縮性増進剤
JPH066535B2 (ja) * 1981-07-30 1994-01-26 バイエル・アクチエンゲゼルシヤフト 心臓収縮性増進剤
JPH05271078A (ja) * 1981-07-30 1993-10-19 Bayer Ag ジヒドロピリジン類
JPS58185821U (ja) * 1982-06-02 1983-12-10 日産自動車株式会社 ウインドシ−ルド
JPS5927871A (ja) * 1982-08-06 1984-02-14 Banyu Pharmaceut Co Ltd ２−カルバモイルオキシアルキル−１，４−ジヒドロピリジン誘導体の新規な製造法
JPH0348180B2 (ja) * 1982-08-06 1991-07-23 Banyu Pharma Co Ltd
JPS6157578A (ja) * 1984-08-17 1986-03-24 ジヨン・ワイス・アンド・ブラザー・リミテツド 複素環式化合物
JPS62145064A (ja) * 1985-12-13 1987-06-29 バイエル・アクチエンゲゼルシヤフト 新規なフツ素含有１，４−ジヒドロピリジン類
JPS62155280A (ja) * 1985-12-18 1987-07-10 バイエル・アクチエンゲゼルシヤフト ４−チエニル−ジヒドロピリジン類
JPS62190187A (ja) * 1986-01-11 1987-08-20 バイエル・アクチエンゲゼルシヤフト ４−アミノアリ−ルジヒドロピリジンラクトン類
JPS62292757A (ja) * 1986-06-12 1987-12-19 Taisho Pharmaceut Co Ltd １，４−ジヒドロピリジン誘導体

Also Published As

Publication number Publication date
AU1554776A (en) 1978-01-05
US4145432A (en) 1979-03-20
AR217321A1 (es) 1980-03-14
YU163376A (en) 1983-01-21
DE2629892A1 (de) 1977-01-27
CH629778A5 (de) 1982-05-14
FI61696B (fi) 1982-05-31
IE43408B1 (en) 1981-02-25
AU510353B2 (en) 1980-06-19
YU41562B (en) 1987-10-31
JPS5948827B2 (ja) 1984-11-29
NL190812C (nl) 1994-09-01
FR2315930A1 (fr) 1977-01-28
IT1068561B (it) 1985-03-21
DK298176A (da) 1977-01-03
NL7607338A (nl) 1977-01-04
NL190812B (nl) 1994-04-05
FR2315930B1 (ja) 1978-11-17
IE43408L (en) 1977-01-02
PH13772A (en) 1980-09-23
GR60422B (en) 1978-05-25
MX3591E (es) 1981-03-24
GB1552911A (en) 1979-09-19
SE7607566L (sv) 1977-01-03
CH637938A5 (de) 1983-08-31
AR213097A1 (es) 1978-12-15
FI761912A (ja) 1977-01-03
CH634052A5 (de) 1983-01-14
FI61696C (fi) 1982-09-10
DD126722A5 (ja) 1977-08-10
SE434049B (sv) 1984-07-02
YU179482A (en) 1983-02-28

Similar Documents

Publication Publication Date Title
JPS525777A (en) 1,4-dihydroxypyridine derivatives
IE781878L (en) Imidazole derivatives
IE820856L (en) Omega-cyano-1,omega-diphenyl-azaalkane derivatives.
BG98124A (en) Active pyrrole-(2,3-)pyridine derivatives
JPS51143674A (en) New derivatives of 4-oxopiperidines
ES452343A1 (es) Procedimiento para la reticulacion de poliolefinas.
ES373231A1 (es) Perfeccionamientos en la fotopolimerizacion de compuestos insaturados.
GR78890B (ja)
JPS52156859A (en) Heterocyclic amide derivatives
DK43384A (da) Bicyclooctanderivater, fremgangsmaade til deres fremstilling og anvendelse heraf
GB1292454A (en) Dyestuffs
ES445944A1 (es) Procedimiento de preparacion de derivados de 8-amino-teofi- lina.
ES449209A1 (es) Procedimiento de preparacion de derivados pentaciclicos.
JPS52100473A (en) Novel azimidebenzamide derivative and its production
JPS52130822A (en) Tetrachloronaphthalic imide derivative and its production
JPS5239674A (en) Imidazole derivatives and agricultural bactericides therefrom
JPS5419987A (en) Pyridazinone derivative and its preparation
GB1226896A (ja)
JPS51131875A (en) A process for preparing novel pyrrolidine derivatives
JPS525795A (en) Preparation of tetrahydro pyridopyrimidinone derivatives
JPS5223051A (en) Preparation of cyclohexane derivatives
ES483307A1 (es) Procedimiento para la preparacion de halogenosulfamoilben- cenos
JPS5416493A (en) Novel josamycin derivatives, their salts, and their preparation
JPS51145548A (en) Stabilizers for polymeric materials
ES450875A1 (es) Un procedimiento para la produccion de nuevos derivados de benzotiadiazol.